Strides Arcolab

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Indian Stride Pharma acquires FDA-approved US manufacturing facility

The facility will meet the enhanced capacity needs for soft gels and will offer an alternate site to Strides’ flagship facility in Bangalore
Finance

Strides Shasun acquires three OTC brands from Moberg Pharma

Indian firm is building an over-the-counter drug franchise in regulated and emerging markets
Finance

Sun Pharma to sell Ranbaxy's CNS divisions to Strides Arcolab

Deal is of strategic significance to growth of Strides branded business in India
Finance

Strides to buy drug assets in Australia and Mauritius from Aspen for approximately US$300m

Part of aim to focus on areas where most value can be added, says Strides
Manufacturing

Stelis Biopharma begins construction of US$60m multiproduct biologics facility in Malaysia

Will incorporate the latest single-use bioreactor systems for scale-up and process development

Vietnam bans companies making \'substandard\' drugs

Companies banned include 45 Indian pharmaceutical companies along with others from Korea, France and Pakistan
Finance

US regulators put conditions of Mylan Agila deal

Companies will have to divest 11 generic injectable drugs as a condition of approving the deal
Subscribe now